SCHEMBL14643285

SCHEMBL14643285

CS(=O)(=O)NCc1nc2cnc3cccnc3c2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.39
GAA P10253 1/20 0.39
ALOX15 P16050 1/20 0.37
HTT P42858 1/20 0.37
GLO1 Q04760 1/20 0.37
KDM4E B2RXH2 1/20 0.35
KMT2A Q03164 1/20 0.34
SLC40A1 Q9NP59 1/20 0.33
DRD4 P21917 1/20 0.33
NAMPT P43490 1/20 0.33
HTR5A P47898 1/20 0.33
ALDH1A1 P00352 1/20 0.33
PKM P14618 1/20 0.33
JAK1 P23458 3/20 0.32
POLB P06746 1/20 0.32
NPC1 O15118 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14643938 0.82 GAA (0.43) SMN1; SMN2GAAALDH1A1PKMJAK1
SCHEMBL14643387 0.79 LMNA (0.39) SMN1; SMN2KDM4EKMT2ASLC40A1ALDH1A1
SCHEMBL204605 0.77 CSNK2A1 (0.39) SMN1; SMN2GAAALOX15HTTGLO1
SCHEMBL14644491 0.76 KDM4E (0.39) SMN1; SMN2GAAALOX15HTTKDM4E
SCHEMBL14644522 0.74 JAK1 (0.51) JAK1
SCHEMBL311171 0.71 KDM4E (0.41) SMN1; SMN2ALOX15HTTKDM4EALDH1A1
SCHEMBL311312 0.68 KDM4E (0.41) SMN1; SMN2ALOX15HTTKDM4EKMT2A
SCHEMBL1490778 0.68 NUDT1 (0.42) SMN1; SMN2GAAALOX15HTTKDM4E
SCHEMBL18658916 0.68 KDM4E (0.41) SMN1; SMN2KDM4ENPC1TP53MAPT
SCHEMBL2086309 0.68 KDM4E (0.39) SMN1; SMN2ALOX15HTTKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013007768-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF AS JAK INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2013-01-17 WO disclosed